LES ALCALOIDES DE L'ERGOT DE SEIGLE ET LEURS EFFETS SECONDAIRESLOUPI E; VIGNEAU C; ROTIVEL Y et al.1982; LYON PHARM.; ISSN 0024-7804; FRA; DA. 1982; VOL. 33; NO 2; PP. 105-106; BIBL. 9 REF.Article

Quantitative studies of the effects of aging, meclofenoxate, and dihydroergotoxine on intraneuronal lipopigment accumulation in the ratDOWSON, J. H.Experimental gerontology. 1985, Vol 20, Num 6, pp 333-340, issn 0531-5565Article

ERGOTS REVISITED-PHARMACOLOGY OF NEW ERGOT DERIVATIVES.1978; FEDER. PROC.; U.S.A.; DA. 1978; VOL. 37; NO 8; PP. 2176-2209; BIBL. DISSEM.Article

INTERNATIONAL WORKSHOP ON ERGOT ALKALOIDS; ROME; 1976.1978; PHARMACOLOGY; SWITZ.; DA. 1978; VOL. 16; SUPPL. 1; PP. 1-213; BIBL. DISSEM.Conference Paper

DIE BEHANDLUNG DER AKROMEGALIE MIT BROMOCRIPTIN. = LE TRAITEMENT DE L'ACROMEGALIE PAR LA BROMOCRIPTINEKOBBERLING J; SCHWINN G; DIRKS H et al.1975; DTSCHE MED. WSCHR.; DTSCH.; DA. 1975; VOL. 100; NO 29; PP. 1540-1542; ABS. ANGL.; BIBL. 10 REF.Article

THERAPIE DER MIGRAENE = LE TRAITEMENT DE LA MIGRAINEMUMENTHALER M.1974; REV. THERAPEUT.; SUISSE; DA. 1974; VOL. 31; NO 11; PP. 797-803; ABS. FR. ANGL.; BIBL. 55 REF.Article

EFFECTS OF DIHYDROERGOTAMINE ON GLUCOSE AND GALACTOSE TOLERANCE IN THE RABBIT = LES EFFETS DE LA DIHYDROERGOTAMINE SUR LA TOLERANCE DU GLUCOSE ET DU GALACTOSE CHEZ LE LAPINWEBLING DDA.1973; J. PHARM. PHARMACOL.; G.B.; DA. 1973; VOL. 25; NO 6; PP. 500-501; BIBL. 3REF.Serial Issue

A STUDENT EXPERIMENT IN PHARMACOGNOSY: THE EFFECT OF TRYPTOPHAN ON ERGOT ALKALOID BIOSYNTHESISROBBERS JE.1972; AMER. J. PHARM. EDUC.; U.S.A.; DA. 1972; VOL. 36; NO 4; PP. 598-602; BIBL. 4REF.Serial Issue

ACCIDENTS ISCHEMIQUES DUS AUX DERIVES DE L'ERGOT DE SEIGLE: A PROPOS DE CINQ OBSERVATIONSRAHAL JOSEPH.1980; ; FRA; DA. 1980; 796; 97-XIII P.: ILL.; 30 CM; BIBL. 97 REF.; TH.: MED./ANGERS/1980Thesis

INHIBITION OF LACTATION IN RABBITS BY 2-BR-ALPHA -ERGOKRYPTINE-MESILATE (CB 154)FLUECKIGER E; BILLETER E; WAGNER HR et al.1976; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1976; VOL. 26; NO 1; PP. 51-53; ABS. ALLEM.; BIBL. 14 REF.Article

LA HYDERGINA EN EL TRATAMIENTO SINTOMATICO DE LA INSUFICIENCIA VASCULAR CEREBRAL = L'HYDERGINE DANS LE TRAITEMENT SYMPTOMATIQUE DE L'INSUFFISANCE VASCULAIRE CEREBRALEREYNA OVIEDO C.1973; MEDICINA; MEX.; DA. 1973; VOL. 53; NO 1154; PP. 175-182; ABS. ANGL.; BIBL. 6REF.Serial Issue

PREPARATION OF ERGOT ALKALOIDSMANSA RAM; SURI JL; ANAND AS et al.1972; RES. AND INDUSTRY; INDIA; DA. 1972; VOL. 17; NO 1; PP. 8; BIBL. 1REF.Serial Issue

NIDATION INHIBITION BY SIMPLE ERGOLINE DERIVATIVES = INHIBITION DE LA NIDATION PAR DES DERIVES SIMPLES DE L'ERGOLINEREZABEK K; CASSADY JM; FLOSS HG et al.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 6; PP. 1045-1046; BIBL. 6 REF.Article

ERGOT PHYSIOLOGY. THE PRODUCTION OF ERGOT ALKALOID IN SAPROPHYTIC CULTURE BY A HOMOKARYOTIC STRAIN OF ERGOTROBBERS JE; JONES LG; KRUPINSKI VM et al.1974; LLOYDIA; E.U.; DA. 1974; VOL. 37; NO 1; PP. 108-111; BIBL. 12REF.Article

THE BIOSYNTHESIS OF ERGOT ALKALOIDSTHOMAS R; BASSETT RA.1972; PROGR. PHYTOCHEM.; G.B.; DA. 1972; VOL. 3; PP. 47-111; BIBL. 5 P. 1/2Serial Issue

THIN-LAYER CHROMATOGRAPHY OF LYSERGIDE AND OTHER ERGOT ALKALOIDS = CHROMATOGRAPHIE EN COUCHE MINCE DU LYSERGIDE ET D'AUTRES ALCALOIDES DE L'ERGOTFOWLER R; GOMM PJ; PATTERSON DA et al.1972; J. CHROMATOGR.; NETHERL.; DA. 1972; VOL. 72; NO 2; PP. 351-357; BIBL. 12REF.Serial Issue

ANTAGONISM OF 2-BR-ALPHA -ERGOKRYPTINE-METHANESULFONATE (CB 154) TO CERTAIN ENDOCRINE ACTIONS OF CENTRALLY ACTIVE DRUGS = ANTAGONISME DE LA BR-2-ALPHA -ERGOCRYPTINE METHANESULFONATE (CB154) A L'EGARD DE CERTAINES ACTIONS ENDOCRINES DES DROGUES A ACTION CENTRALEFLUECKIGER E; LUTTERBECK PM; WAGNER HR et al.1972; EXPERIENTIA; SUISSE; DA. 1972; VOL. 28; NO 8; PP. 924-925; ABS. ALLEM.; BIBL. 10REF.Article

EX VIVO STUDIES AFTER ORAL TREATMENT OF THE BEAGLE WITH DIHYDROERGOTAMINEMULLER SCHWEINITZER E; ROSENTHALER J.1983; EUROPEAN JOURNAL OF PHARMACOLOGY; ISSN 0014-2999; NLD; DA. 1983; VOL. 89; NO 1-2; PP. 1-8; BIBL. 24 REF.Article

BIOSYNTHESE DES PEPTIDTEILS DER MUTTERKORNALKALOIDE VOM CYCLOL-TYP. = BIOSYNTHESE DE FRACTIONS PEPTIDIQUE DU TYPE CYCLOL DANS LES ALCALOIDES DE L'ERGOTGROGER D.1975; PLANTA MED.; ALLEM.; DA. 1975; VOL. 28; NO 1; PP. 37-51; ABS. ANGL.; BIBL. 1 P.Article

DOSAGE PHOTODENSITOMETRIQUE IN SITU DES ALCALOIDES DANS SECALE CORNUTUMVANHAELEN M; VANHAELEN FASTRE R.1972; J. CHROMATOGR.; NETHERL.; DA. 1972; VOL. 72; NO 1; PP. 139-144; ABS. ANGL.; BIBL. 4 REF.Serial Issue

BC 105, ET NYT MIGRAENEMIDDEL = UN NOUVEAU MEDICAMENT POUR LA MIGRAINEJORGENSEN RS.1972; UGESKR. LAEGER; DANM.; DA. 1972; VOL. 134; NO 43; PP. 2266-2268; ABS. ANGL.; BIBL. 14REF.Serial Issue

Clavines: new antibiotics with cytostatic activityEICH, E; EICHBERG, D; MÜLLER, W. E. G et al.Biochemical pharmacology. 1984, Vol 33, Num 4, pp 523-526, issn 0006-2952Article

Hemodynamic effects of two ergot derivatives in the conscious spontaneously hypertensive ratSUSIC, D; DJORDJEVIC, N; KENTERA, D et al.Pharmacology. 1984, Vol 29, Num 4, pp 215-223, issn 0031-7012Article

Interaction of lisuride with monoamine receptors on human blood plateletsGLUSA, E; MARKWARDT, F.Biochemical pharmacology. 1984, Vol 33, Num 3, pp 493-496, issn 0006-2952Article

Intérêt et place du vasobral dans les troubles périménopausiques = Interest and place of vasdoral in perimenopausal disordersCOSSARD, F; PAUQUET, M; SENTENAC, J et al.Gazette médicale de France (1969). 1985, Vol 92, Num 33, pp 100-103, issn 0016-5557Article